Clinical trial
Combination Therapy for Neovascular Age Related Macular Degeneration
NCT00447031 · Yonsei University, Other · Withdrawn
Key facts
| NCT number | NCT00447031 |
|---|---|
| Title | Combination Therapy for Neovascular Age Related Macular Degeneration |
| Official title | Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone Acetonide Injection Versus Intravitreal Bevacizumab for Age Related Macular Degeneration |
| Lead sponsor | Yonsei University, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | intravitreal bevacizumab and triamcinolone acetonide |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Mar 13, 2007 |
| Last update posted | Feb 9, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: